Literature DB >> 2208803

Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis.

C S Raine1, S C Lee, L C Scheinberg, A M Duijvestin, A H Cross.   

Abstract

The observation of lymphocyte adhesion/homing molecules with ligands (integrins and vascular addressins) on endothelial cells (EC) within target organs during a number of nonlymphoid chronic inflammatory conditions is occurring with increasing frequency. On the basis of evidence from the literature and pilot data on the localization of the putative vascular addressin for humans, HECA-452, in central nervous system (CNS) tissue, it is suggested that molecular recognition on CNS EC might play a pathogenetic role during immune-mediated demyelination in multiple sclerosis (MS). In one of six cases of MS, a case displaying a particularly malignant course, HECA-452 was specifically and reproducibly demonstrated on postcapillary venules in periplaque white matter beyond the zone of active inflammation. In the same case, CD8+ T cells predominated over CD4+ cells. In no case studied were EC positive for HLA-DR (Ia), in contrast to previous reports. Perivascular Ia positivity was common and was always associated with foamy macrophages or pericytes. In view of the occurrence of semiorganized lymphoid collections in a number of chronic inflammatory conditions, several of which are associated with expression of HEV markers, and in MS, it is concluded that examination of molecular recognition events on lymphocytes and EC within the CNS in MS is an area worthy of further study and an area with considerable therapeutic import.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208803     DOI: 10.1016/0090-1229(90)90032-l

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  8 in total

Review 1.  Molecular biology of the blood-brain barrier.

Authors:  William M Pardridge
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

Review 2.  Mechanisms of immune-mediated demyelinating disease of the central nervous system.

Authors:  D Baker; A N Davison
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 3.  Will complex carbohydrate ligands of vascular selectins be the next generation of non-steroidal anti-inflammatory drugs?

Authors:  J L Winkelhake
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

Review 4.  Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Authors:  Divya Sagar; Catherine Foss; Rasha El Baz; Martin G Pomper; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

Review 5.  Pathophysiology of the blood-brain barrier.

Authors:  K Selmaj
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone.

Authors:  D Baker; J K O'Neill; A N Davison; J L Turk
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 7.  Development and Cell Biology of the Blood-Brain Barrier.

Authors:  Urs H Langen; Swathi Ayloo; Chenghua Gu
Journal:  Annu Rev Cell Dev Biol       Date:  2019-07-12       Impact factor: 13.827

Review 8.  The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels.

Authors:  B A 't Hart; H P Brok; S Amor; R E Bontrop
Journal:  Hum Immunol       Date:  2001-12       Impact factor: 2.850

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.